Efficacy of internal administration of Tilakanda Kshara in the management of benign prostatic hyperplasia- A pre-post study
Abstract
Background: Benign Prostatic Hyperplasia (BPH) is a prevalent, non-cancerous tumour affecting aging men, significantly contributing to lower urinary tract symptoms (LUTS) worldwide. This condition substantially impacts quality of life. Prevalence of histologic BPH with age is approximately 20% (41-50 years), 50% (51-60 years), and over 90% (above 80 years). Treatment modalities span from conservative management (watchful waiting) to Medical therapy and Surgical intervention. According to Ayurvedic texts, Mutra rogas' severity manifests as vibhanda (obstruction), predominantly observed in Mutraghata. While no single disease mirrors Benign Prostatic Hyperplasia (BPH) exactly, Mutragranthi, described under Mutraghata, shares striking similarities. Objectives: To evaluate the efficacy of internal administration of tilakanda kshara in the management of Benign Prostatic Hyperplasia. Materials and methods: This is a single group pre- post interventional study conducted on 20 participants from OPD and IPD department of salya tantra, Govt Ayurveda College, Thiruvananthapuram. Participants diagnosed with BPH was subjected to internal administration of kshara for a period of 30 days. Conclusion: A majority of the participants experienced significant relief from symptoms of BPH, even though there was no statistically significant reduction in prostate size. Furthermore, the post-void residual urine volume showed a significant reduction in most participants, both clinically and…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.